|
Phenotypic Information (metabolism pathway, cancer, disease, phenome) | |
Gene-Gene Network Information: Co-Expression Network, Interacting Genes & KEGG | |
Gene Summary for FDPS |
Basic gene info. | Gene symbol | FDPS |
Gene name | farnesyl diphosphate synthase | |
Synonyms | FPPS|FPS | |
Cytomap | UCSC genome browser: 1q22 | |
Genomic location | chr1 :155278538-155290457 | |
Type of gene | protein-coding | |
RefGenes | NM_001135821.1, NM_001135822.1,NM_001242824.1,NM_001242825.1,NM_002004.3, | |
Ensembl id | ENSG00000160752 | |
Description | (2E,6E)-farnesyl diphosphate synthaseFPP synthaseFPP synthetasedimethylallyltranstransferasefarnesyl pyrophosphate synthasefarnesyl pyrophosphate synthetase, dimethylallyltranstransferase, geranyltranstransferasegeranyltranstransferase | |
Modification date | 20141207 | |
dbXrefs | MIM : 134629 | |
HGNC : HGNC | ||
Ensembl : ENSG00000160752 | ||
HPRD : 00606 | ||
Vega : OTTHUMG00000013909 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_FDPS | |
BioGPS: 2224 | ||
Gene Expression Atlas: ENSG00000160752 | ||
The Human Protein Atlas: ENSG00000160752 | ||
Pathway | NCI Pathway Interaction Database: FDPS | |
KEGG: FDPS | ||
REACTOME: FDPS | ||
ConsensusPathDB | ||
Pathway Commons: FDPS | ||
Metabolism | MetaCyc: FDPS | |
HUMANCyc: FDPS | ||
Regulation | Ensembl's Regulation: ENSG00000160752 | |
miRBase: chr1 :155,278,538-155,290,457 | ||
TargetScan: NM_001135821 | ||
cisRED: ENSG00000160752 | ||
Context | iHOP: FDPS | |
cancer metabolism search in PubMed: FDPS | ||
UCL Cancer Institute: FDPS | ||
Assigned class in ccmGDB | C |
Top |
Phenotypic Information for FDPS(metabolism pathway, cancer, disease, phenome) |
Cancer Description | |
Cancer | CGAP: FDPS |
Familial Cancer Database: FDPS |
* This gene is included in those cancer gene databases. |
Oncogene 1 | Significant driver gene in |
cf) number; DB name 1 Oncogene; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 2 Tumor Suppressor gene; https://bioinfo.uth.edu/TSGene/, 3 Cancer Gene Census; http://www.nature.com/nrc/journal/v4/n3/abs/nrc1299.html, 4 CancerGenes; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 5 Network of Cancer Gene; http://ncg.kcl.ac.uk/index.php, 1Therapeutic Vulnerabilities in Cancer; http://cbio.mskcc.org/cancergenomics/statius/ |
Metabolic Pathway Description | |
REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS |
Others | |
OMIM | |
Orphanet | |
Disease | KEGG Disease: FDPS |
MedGen: FDPS (Human Medical Genetics with Condition) | |
ClinVar: FDPS | |
Phenotype | MGI: FDPS (International Mouse Phenotyping Consortium) |
PhenomicDB: FDPS |
Mutations for FDPS |
* Under tables are showing count per each tissue to give us broad intuition about tissue specific mutation patterns.You can go to the detailed page for each mutation database's web site. |
Structural Variants in COSMIC: go to COSMIC mutation histogram |
- Statistics for Tissue and Mutation type | Top |
- For Inter-chromosomal Variations |
* Inter-chromosomal variantions includes 'interchromosomal amplicon to amplicon', 'interchromosomal amplicon to non-amplified dna', 'interchromosomal insertion', 'Interchromosomal unknown type'. |
- For Intra-chromosomal Variations |
* Intra-chromosomal variantions includes 'intrachromosomal amplicon to amplicon', 'intrachromosomal amplicon to non-amplified dna', 'intrachromosomal deletion', 'intrachromosomal fold-back inversion', 'intrachromosomal inversion', 'intrachromosomal tandem duplication', 'Intrachromosomal unknown type', 'intrachromosomal with inverted orientation', 'intrachromosomal with non-inverted orientation'. |
Sample | Symbol_a | Chr_a | Start_a | End_a | Symbol_b | Chr_b | Start_b | End_b |
breast | FDPS | chr1 | 155286796 | 155287196 | ASH1L | chr1 | 155306027 | 155306427 |
ovary | FDPS | chr1 | 155288695 | 155288715 | DCST2 | chr1 | 154991943 | 154991963 |
pancreas | FDPS | chr1 | 155279838 | 155279858 | chr2 | 16131749 | 16131769 |
cf) Tissue number; Tissue name (1;Breast, 2;Central_nervous_system, 3;Haematopoietic_and_lymphoid_tissue, 4;Large_intestine, 5;Liver, 6;Lung, 7;Ovary, 8;Pancreas, 9;Prostate, 10;Skin, 11;Soft_tissue, 12;Upper_aerodigestive_tract) |
Related fusion transcripts : go to Chitars2.0 |
* From mRNA Sanger sequences, Chitars2.0 arranged chimeric transcripts. This table shows FDPS related fusion information. |
ID | Head Gene | Tail Gene | Accession | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a |
BG491331 | PMM2 | 2 | 666 | 16 | 8891714 | 8906963 | FDPS | 667 | 899 | 1 | 155287732 | 155288485 | |
BM809442 | PMM2 | 1 | 664 | 16 | 8891715 | 8906963 | FDPS | 665 | 965 | 1 | 155287732 | 155288655 | |
BF512311 | FDPS | 18 | 159 | 1 | 155290315 | 155290456 | ATP13A2 | 151 | 446 | 1 | 17316435 | 17318299 | |
CB046420 | GPI | 24 | 326 | 19 | 34868441 | 34870455 | FDPS | 322 | 436 | 1 | 155290342 | 155290456 | |
BM555536 | PMM2 | 1 | 665 | 16 | 8891714 | 8906963 | FDPS | 666 | 970 | 1 | 155287732 | 155288545 | |
CA312317 | VPS52 | 1 | 138 | 6 | 4708320 | 4708717 | FDPS | 133 | 762 | 1 | 155284139 | 155285195 | |
CB046419 | FDPS | 35 | 149 | 1 | 155290342 | 155290456 | GPI | 145 | 447 | 19 | 34868441 | 34870455 | |
BF928396 | FDPS | 16 | 216 | 1 | 155289617 | 155290297 | TGIF2 | 207 | 416 | 20 | 35215649 | 35215858 |
Other DBs for Structural Variants |
Top |
Copy Number Variations in COSMIC: go to COSMIC mutation CNV/Expr |
There's no copy number variation information in COSMIC data for this gene. |
Top |
SNV Counts per Each Loci in COSMIC data: go to COSMIC point mutation |
|
Top |
Somatic Mutation Counts per Tissue in COSMIC data |
Stat. for Non-Synonymous SNVs (# total SNVs=34) | (# total SNVs=15) |
(# total SNVs=3) | (# total SNVs=0) |
Top |
Top 10 SNVs Having the Most Samples in COSMIC data |
* When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site,primary_histology,mutation(aa),pubmedID. |
GRCh37 position | Mutation(aa) | Unique sampleID count |
chr1:155279651-155279651 | p.E24V | 2 |
chr1:155287783-155287783 | p.R178C | 2 |
chr1:155287966-155287966 | p.V190M | 2 |
chr1:155288068-155288068 | p.E224K | 2 |
chr1:155289467-155289467 | p.F304L | 2 |
chr1:155287769-155287769 | p.D173A | 1 |
chr1:155290322-155290322 | p.L394L | 1 |
chr1:155288469-155288469 | p.T233S | 1 |
chr1:155279946-155279946 | p.D97H | 1 |
chr1:155289628-155289628 | p.K323T | 1 |
Top |
SNV Counts per Each Loci in TCGA data |
|
Point Mutation/ Tissue ID | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 |
# sample |   | 3 | 1 | 7 | 2 |   | 2 |   | 2 |   |   | 6 | 1 |   |   |   | 3 | 8 |   | 7 |
# mutation |   | 3 | 1 | 7 | 2 |   | 2 |   | 2 |   |   | 6 | 1 |   |   |   | 3 | 8 |   | 8 |
nonsynonymous SNV |   | 1 | 1 | 6 | 2 |   | 2 |   | 1 |   |   | 3 | 1 |   |   |   | 3 | 8 |   | 7 |
synonymous SNV |   | 2 |   | 2 |   |   |   |   | 1 |   |   | 3 |   |   |   |   |   |   |   | 1 |
cf) Tissue ID; Tissue type (1; BLCA[Bladder Urothelial Carcinoma], 2; BRCA[Breast invasive carcinoma], 3; CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], 4; COAD[Colon adenocarcinoma], 5; GBM[Glioblastoma multiforme], 6; Glioma Low Grade, 7; HNSC[Head and Neck squamous cell carcinoma], 8; KICH[Kidney Chromophobe], 9; KIRC[Kidney renal clear cell carcinoma], 10; KIRP[Kidney renal papillary cell carcinoma], 11; LAML[Acute Myeloid Leukemia], 12; LUAD[Lung adenocarcinoma], 13; LUSC[Lung squamous cell carcinoma], 14; OV[Ovarian serous cystadenocarcinoma ], 15; PAAD[Pancreatic adenocarcinoma], 16; PRAD[Prostate adenocarcinoma], 17; SKCM[Skin Cutaneous Melanoma], 18:STAD[Stomach adenocarcinoma], 19:THCA[Thyroid carcinoma], 20:UCEC[Uterine Corpus Endometrial Carcinoma]) |
Top |
Top 10 SNVs Having the Most Samples in TCGA data |
* We represented just top 10 SNVs. When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site, primary_histology, mutation(aa), pubmedID. |
Genomic Position | Mutation(aa) | Unique sampleID count |
chr1:155288068 | p.E53K,FDPS | 2 |
chr1:155279838 | p.Q5H,FDPS | 1 |
chr1:155290280 | p.V19M,FDPS | 1 |
chr1:155282164 | p.S218N,FDPS | 1 |
chr1:155288469 | p.S22F,FDPS | 1 |
chr1:155279870 | p.D26G,FDPS | 1 |
chr1:155290306 | p.E225K,FDPS | 1 |
chr1:155282171 | p.E30K,FDPS | 1 |
chr1:155288489 | p.L40L,FDPS | 1 |
chr1:155279920 | p.V235I,FDPS | 1 |
Other DBs for Point Mutations |
Copy Number for FDPS in TCGA |
* Copy number data were extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered on Jan-05-2015. Function ProcessCNAData in TCGA-Assembler package was used to obtain gene-level copy number value which is calculated as the average copy number of the genomic region of a gene. |
cf) Tissue ID[Tissue type]: BLCA[Bladder Urothelial Carcinoma], BRCA[Breast invasive carcinoma], CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], COAD[Colon adenocarcinoma], GBM[Glioblastoma multiforme], Glioma Low Grade, HNSC[Head and Neck squamous cell carcinoma], KICH[Kidney Chromophobe], KIRC[Kidney renal clear cell carcinoma], KIRP[Kidney renal papillary cell carcinoma], LAML[Acute Myeloid Leukemia], LUAD[Lung adenocarcinoma], LUSC[Lung squamous cell carcinoma], OV[Ovarian serous cystadenocarcinoma ], PAAD[Pancreatic adenocarcinoma], PRAD[Prostate adenocarcinoma], SKCM[Skin Cutaneous Melanoma], STAD[Stomach adenocarcinoma], THCA[Thyroid carcinoma], UCEC[Uterine Corpus Endometrial Carcinoma] |
Top |
Gene Expression for FDPS |
Gene Expression in Cancer Cell-lines (CCLE) |
* CCLE gene expression data were extracted from CCLE_Expression_Entrez_2012-10-18.res: Gene-centric RMA-normalized mRNA expression data. |
Differential Gene Expression in Primary Tumors (TCGA) |
* Normalized gene expression data of RNASeqV2 was extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered at Jan-05-2015. Only eight cancer types have enough normal control samples for differential expression analysis. (t test, adjusted p<0.05 (using Benjamini-Hochberg FDR)) |
Top |
CNV vs Gene Expression Plot |
* This plots show the correlation between CNV and gene expression. |
Top |
Gene-Gene Network Information |
Co-Expressed gene's network Plot |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
ACAT2,ADAM15,CKS1B,DAP3,EBP,FDPS,FLAD1, HAX1,HDGF,JTB,MFSD2B,MVD,NDUFS2,PRCC, SLC50A1,RUSC1,MSMO1,SCAMP3,TAGLN2,UBE2Q1,ZFP57 | AACS,ACAT2,AKR1A1,DBI,DHCR7,EBP,FDPS, FIBCD1,G6PD,GGT1,GGTLC2,GSS,HIST1H3D,MFSD7, MMAB,MVD,MVK,NUDT8,P4HB,PEX10,QPRT | ||||
ACAT2,BPNT1,CYP51A1,DHCR24,ENSA,FDPS,FGFBP1, FH,HSD17B7,IDI1,LGTN,LSS,MTX1,MVD, NDUFS2,RAB25,MSMO1,SDHC,TIMM17A,TPM3,UQCRFS1 | ACAT2,BATF3,C14orf1,C6orf223,EBP,FDFT1,FDPS, HSD17B7,IDI1,INSIG1,MMAB,MVD,MVK,NSDHL, PLA2G2A,PLA2G3,PSMA3,RDH11,MSMO1,SC5D,STARD4 |
Co-Expressed gene's Protein-protein interaction Network Plot |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
Top |
Interacting Genes (from Pathway Commons) |
Top |
Pharmacological Information for FDPS |
Cross-referenced pharmacological DB IDs from Uniprot |
DB Category | DB Name | DB's ID and Url link |
Drug-Gene Interaction Network |
* Gene Centered Interaction Network. |
* Drug Centered Interaction Network. |
DrugBank ID | Target Name | Drug Groups | Generic Name | Drug Centered Network | Drug Structure |
DB00282 | farnesyl diphosphate synthase | approved | Pamidronate | ||
DB00399 | farnesyl diphosphate synthase | approved | Zoledronate | ||
DB00630 | farnesyl diphosphate synthase | approved | Alendronate | ||
DB00710 | farnesyl diphosphate synthase | approved; investigational | Ibandronate | ||
DB00884 | farnesyl diphosphate synthase | approved; investigational | Risedronate | ||
DB01785 | farnesyl diphosphate synthase | experimental | Dimethylallyl Diphosphate | ||
DB02508 | farnesyl diphosphate synthase | experimental | Isopentyl Pyrophosphate | ||
DB02552 | farnesyl diphosphate synthase | experimental | Geranyl Diphosphate | ||
DB04714 | farnesyl diphosphate synthase | experimental | ISOPENTENYL PYROPHOSPHATE | ||
DB07780 | farnesyl diphosphate synthase | experimental | FARNESYL DIPHOSPHATE | ||
DB07841 | farnesyl diphosphate synthase | experimental | GERANYLGERANYL DIPHOSPHATE | ||
DB00481 | farnesyl diphosphate synthase | approved; investigational | Raloxifene |
Top |
Cross referenced IDs for FDPS |
* We obtained these cross-references from Uniprot database. It covers 150 different DBs, 18 categories. http://www.uniprot.org/help/cross_references_section |
Copyright © 2016-Present - The Univsersity of Texas Health Science Center at Houston @ |